These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis. White AA; Doherty TA Am J Rhinol Allergy; 2018 Jan; 32(1):7-11. PubMed ID: 29336282 [TBL] [Abstract][Full Text] [Related]
5. Eosinophil production of prostaglandin D Feng X; Ramsden MK; Negri J; Baker MG; Payne SC; Borish L; Steinke JW J Allergy Clin Immunol; 2016 Oct; 138(4):1089-1097.e3. PubMed ID: 27423494 [TBL] [Abstract][Full Text] [Related]
6. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease. Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369 [TBL] [Abstract][Full Text] [Related]
7. A trial of type 12 purinergic (P2Y Laidlaw TM; Cahill KN; Cardet JC; Murphy K; Cui J; Dioneda B; Kothari P; Raby BA; Israel E; Boyce JA J Allergy Clin Immunol; 2019 Jan; 143(1):316-324.e7. PubMed ID: 29890239 [TBL] [Abstract][Full Text] [Related]
8. Lipid-mediated innate lymphoid cell recruitment and activation in aspirin-exacerbated respiratory disease. Cavagnero KJ; Doherty TA Ann Allergy Asthma Immunol; 2021 Feb; 126(2):135-142. PubMed ID: 32950684 [TBL] [Abstract][Full Text] [Related]
9. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease. Laidlaw TM; Buchheit KM; Cahill KN; Hacker J; Cho L; Cui J; Feng C; Chen CC; Le M; Israel E; Boyce JA J Allergy Clin Immunol; 2023 Sep; 152(3):700-710.e3. PubMed ID: 37068712 [TBL] [Abstract][Full Text] [Related]
10. Mediator production and severity of aspirin-induced respiratory reactions: Impact of sampling site and body mass index. Cahill KN; Wu P; Milne GL; Amin T; Singer J; Murphy K; Lewis E; Gapko D; Boyce JA; Buchheit KM; Laidlaw TM J Allergy Clin Immunol; 2022 Jul; 150(1):170-177.e6. PubMed ID: 35026207 [TBL] [Abstract][Full Text] [Related]
11. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics. Mastalerz L; Januszek R; Kaszuba M; Wójcik K; Celejewska-Wójcik N; Gielicz A; Plutecka H; Oleś K; Stręk P; Sanak M Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):163-9. PubMed ID: 26209241 [TBL] [Abstract][Full Text] [Related]
12. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879 [TBL] [Abstract][Full Text] [Related]
20. Association of interleukin-25 levels with development of aspirin induced respiratory diseases. Lee JU; Chang HS; Lee HJ; Bae DJ; Son JH; Park JS; Choi JS; Hwang HG; Park CS Respir Med; 2017 Feb; 123():71-78. PubMed ID: 28137499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]